SCHEMBL4764097

SCHEMBL4764097

COc1cnn[c]c1-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 1/20 0.41
PDGFRA P16234 1/20 0.41
MAPT P10636 3/20 0.40
KMT2A Q03164 1/20 0.40
CASP1 P29466 1/20 0.40
ALDH1A1 P00352 6/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
GAA P10253 2/20 0.38
GLA P06280 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
RECQL P46063 1/20 0.38
FYN P06241 2/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4721748 0.81 GRM5 (0.39) MAPTKMT2ACASP1ALDH1A1SMN1; SMN2
SCHEMBL4765696 0.78 CYP2C9 (0.41) MAPTKMT2AALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL557932 0.77 L3MBTL1 (0.47) MAPTKMT2AALDH1A1SMN1; SMN2GAA
SCHEMBL4721336 0.74 ALDH1A1 (0.40) PDGFRBPDGFRAMAPTKMT2AALDH1A1
SCHEMBL1551998 0.73 AXL (0.36) ALDH1A1SMN1; SMN2LMNAHPGDNPC1
SCHEMBL3766619 0.73 CA12 (0.38) PDGFRBPDGFRAMAPTKMT2ACASP1
SCHEMBL2267409 0.69 ALDH1A1 (0.38) ALDH1A1
SCHEMBL4765616 0.66 CA4 (0.42) MAPTKMT2AALDH1A1SMN1; SMN2GAA
SCHEMBL29414363 0.66 L3MBTL1 (0.46) PDGFRBPDGFRAMAPTKMT2AALDH1A1
SCHEMBL148974 0.66 L3MBTL1 (0.46) PDGFRBPDGFRAMAPTKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080176857-A1 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors PFIZER INC. 2008-07-24 US disclosed
EP-1874780-A1 4-PIPERAZINYLTHIENO[2,3-D]PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS Pharmacia & Upjohn Company LLC (US) 2008-01-09 EP disclosed
WO-2006100591-A1 4-PIPERAZINNYLTHIENO [2,3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS PHARMACIA & UPJOHN COMPANY LLC (US) 2006-09-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176857-A1 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors TBXA2R, P2RY4, PF4 PDGFRB 39/4885PDGFRA 35/4885MAPT 4361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.